Upregulation of AGO2 has been identified in multiple tumor types, such as breast cancer16, colon cancer17, myeloma18, hepatocellular carcinoma19, gastric carcinoma20, and non-melanoma skin cancer21. Here, AGO2 is linked to neoplasm.